At the molecular level, M6k preserves the genetic and transcriptomic profiles of patient-derived MDS samples and retains mutations such as SRSF2, U2AF1, TET2, RUNX1, IDH2, ASXL1. Here, SRSF2 is linked to myelodysplastic syndrome.